New England Journal of Medicine
The New England Journal of Medicine is a leading medical journal providing research, reviews, and commentary on clinical practice and biomedical science.
Effects of Semaglutide on Chronic Kidney Disease in Patients with …
May 24, 2024 · We randomly assigned patients with type 2 diabetes and chronic kidney disease (defined by an estimated glomerular filtration rate [eGFR] of 50 to 75 ml per minute per 1.73 m 2 of body-surface area ...
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Feb 10, 2021 · Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is approved, at doses up to 1 mg administered subcutaneously once weekly, for the treatment of type 2 diabetes in adults and for ...
Climate Change, Extreme Heat, and Health | NEJM
May 15, 2024 · The frequency, duration, and intensity of heat waves in the United States have increased in recent decades ().The annual number of heat waves is now twice that in the 1980s, and the heat wave ...
Effect of Early Treatment with Ivermectin among Patients with …
Mar 30, 2022 · A total of 3515 patients were randomly assigned to receive ivermectin (679 patients), placebo (679), or another intervention (2157). Overall, 100 patients (14.7%) in the ivermectin group had a ...
Sepsis and Septic Shock | New England Journal of Medicine
Dec 4, 2024 · Sepsis, a syndrome of life-threatening, acute organ dysfunction due to a dysregulated response to infection, is a major global health burden. Worldwide, an estimated 48.9 million cases of sepsis ...
Fundamentals of Medical Ethics — A New Perspective Series
Dec 20, 2023 · Ethical issues in medicine have been hashed out for centuries, but advances in medical science often give rise to new ethical dilemmas. At the dawn of hemodialysis, for instance, a 1962 Life ...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Dec 10, 2020 · A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days ...
Beta-Blockers after Myocardial Infarction and Preserved Ejection ...
Apr 7, 2024 · From September 2017 through May 2023, a total of 5020 patients were enrolled (95.4% of whom were from Sweden). The median follow-up was 3.5 years (interquartile range, 2.2 to 4.7).